Studies “consistently show” that the non-intoxicating marijuana component CBD is a potential “anticancer agent across different cancer types”—and that effect applies to dogs as well as humans, according to a new systemic review of the scientific literature.
Numerous studies have investigated how cannabis and its constituents may impact the symptoms and progression of cancer. The new paper published in the journal Frontiers in Veterinary Science examined that preclinical research, which generally indicates that CBD may “inhibit cell proliferation and migration, while inducing apoptosis in various human tumor cells.”
How cannabidiol affects canines has been less rigorously studied compared to humans. That’s despite the fact that the cannabinoid “has been shown to be safe and well-tolerated in dogs, supporting its potential clinical use,” the authors, who are affiliated with the University of Chile, said.
They wrote that since 2015, “some studies have been conducted evaluating CBD in different types of canine cancer,” but “no comprehensive review of these findings has been performed.”
“For this reason, we conducted a systematic review to compile the existing evidence on the anticancer effects of CBD in dogs,” they said, adding that their analysis determined that preclinical studies, largely based on cellular models, often focus on
Read full article on Marijuana Moment
